BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 15508724)

  • 1. [Diaminodiphenylsulfone resistance of Mycobacterium leprae due to mutations in the dihydropteroate synthase gene].
    Kai M
    Nihon Hansenbyo Gakkai Zasshi; 2004 Sep; 73(3):221-6. PubMed ID: 15508724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diaminodiphenylsulfone resistance of Mycobacterium leprae due to mutations in the dihydropteroate synthase gene.
    Kai M; Matsuoka M; Nakata N; Maeda S; Gidoh M; Maeda Y; Hashimoto K; Kobayashi K; Kashiwabara Y
    FEMS Microbiol Lett; 1999 Aug; 177(2):231-5. PubMed ID: 10474189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dapsone resistance does not appear to be associated with a mutation in the dihydropteroate synthase-2 gene of Mycobacterium leprae.
    Gillis TP; Williams DL
    Indian J Lepr; 1999; 71(1):11-8. PubMed ID: 10439322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dihydropteroate synthase mutations in the folP1 gene predict dapsone resistance in relapsed cases of leprosy.
    Cambau E; Carthagena L; Chauffour A; Ji B; Jarlier V
    Clin Infect Dis; 2006 Jan; 42(2):238-41. PubMed ID: 16355335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutation analysis of the Mycobacterium leprae folP1 gene and dapsone resistance.
    Nakata N; Kai M; Makino M
    Antimicrob Agents Chemother; 2011 Feb; 55(2):762-6. PubMed ID: 21115799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dihydropteroate synthase of Mycobacterium leprae and dapsone resistance.
    Williams DL; Spring L; Harris E; Roche P; Gillis TP
    Antimicrob Agents Chemother; 2000 Jun; 44(6):1530-7. PubMed ID: 10817704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of a potential lead compound for treating leprosy with dapsone resistance mutation in M. leprae folP1.
    Nisha J; Ramanathan K; Nawaz Khan F; Dhanasekaran D; Shanthi V
    Mol Biosyst; 2016 Jun; 12(7):2178-88. PubMed ID: 27120972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computational Modelling of Dapsone Interaction With Dihydropteroate Synthase in Mycobacterium leprae; Insights Into Molecular Basis of Dapsone Resistance in Leprosy.
    Chaitanya V S; Das M; Bhat P; Ebenezer M
    J Cell Biochem; 2015 Oct; 116(10):2293-303. PubMed ID: 25833404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dapsone resistance in Mycobacterium leprae.
    Gillis TP; Williams DL
    Lepr Rev; 2000 Dec; 71 Suppl():S91-5. PubMed ID: 11201896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A drug-resistant leprosy case detected by DNA sequence analysis from a relapsed Mexican leprosy patient.
    Lopez-Roa RI; Fafutis-Morris M; Masanori M
    Rev Latinoam Microbiol; 2006; 48(3-4):256-9. PubMed ID: 18293659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of mutations in folp1, rpoB and gyrA genes of M. leprae by PCR- direct sequencing--a rapid tool for screening drug resistance in leprosy.
    Sekar B; Arunagiri K; Kumar BN; Narayanan S; Menaka K; Oommen PK
    Lepr Rev; 2011 Mar; 82(1):36-45. PubMed ID: 21644470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular docking and simulation study for synthesis of alternative dapsone derivative as a newer antileprosy drug in multidrug therapy.
    Swain SS; Paidesetty SK; Dehury B; Sahoo J; Vedithi SC; Mahapatra N; Hussain T; Padhy RN
    J Cell Biochem; 2018 Dec; 119(12):9838-9852. PubMed ID: 30125973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple docking analysis and
    Halder ST; Dhorajiwala TM; Samant LR
    Int J Mycobacteriol; 2019; 8(3):229-236. PubMed ID: 31512598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Multi-drug resistant Mycobacterium leprae from patients with leprosy].
    Maeda S
    Nihon Hansenbyo Gakkai Zasshi; 2004 Sep; 73(3):227-33. PubMed ID: 15508725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory effect of natural compounds on Dihydropteroate synthase of
    Khan M; Khan S; Bushara NZA; Ali R; Tabassum Z; Ishrat R; Marouf HA; Sherwani S; Mirza S; Haque S
    J Biomol Struct Dyn; 2023; 41(23):13857-13872. PubMed ID: 37070201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prevalence of folP1 mutations associated with clinical resistance to dapsone, in Mycobacterium leprae isolates from South Korea.
    Lee SB; Kim SK; Kang TJ; Chae GT; Chun JH; Shin HK; Kim JP; Ko YH; Kim NH
    Ann Trop Med Parasitol; 2001 Jun; 95(4):429-32. PubMed ID: 11454253
    [No Abstract]   [Full Text] [Related]  

  • 17. Drug resistance in Mycobacterium leprae from patients with leprosy in China.
    Liu D; Zhang Q; Sun Y; Wang C; Zhang Y; Fu X; Chen M; Zhou G; Yu X; Wang J; Liu H; Zhang F
    Clin Exp Dermatol; 2015 Dec; 40(8):908-11. PubMed ID: 25991507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations in genes related to drug resistance in Mycobacterium leprae isolates from leprosy patients in Korea.
    You EY; Kang TJ; Kim SK; Lee SB; Chae GT
    J Infect; 2005 Jan; 50(1):6-11. PubMed ID: 15603834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous detection of Mycobacterium leprae and its susceptibility to dapsone using DNA heteroduplex analysis.
    Williams DL; Pittman TL; Gillis TP; Matsuoka M; Kashiwabara Y
    J Clin Microbiol; 2001 Jun; 39(6):2083-8. PubMed ID: 11376039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leprosy Drug Resistance Surveillance in Colombia: The Experience of a Sentinel Country.
    Beltrán-Alzate C; López Díaz F; Romero-Montoya M; Sakamuri R; Li W; Kimura M; Brennan P; Cardona-Castro N
    PLoS Negl Trop Dis; 2016 Oct; 10(10):e0005041. PubMed ID: 27706165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.